Showing results (201-210 of 523) with videos related to
Sort By:
Pageof 53
Revista Espanola De Patologia : Publicacion Oficial De La Sociedad Espanola De Anatomia Patologica Y De La Sociedad Espanola De Citologia|October 5, 2020
[Liquid biopsy in oncology: A consensus statement of the Spanish Society of Pathology and the Spanish Society of Medical Oncology]Ramiro Álvarez-Alegret, Federico Rojo Todo, Pilar Garrido, et al.Acta Cytologica|December 5, 2012
Circulating tumor cells in lung cancerRachel Young, Emma Pailler, Fanny Billiot, et al.Bulletin Du Cancer|December 5, 2014
[Focus on targeting the Ras-MAPK pathway: the Mek inhibitors]Capucine Baldini, Boris Duchemann, Antoine Hollebecque, et al.Plos One|October 11, 2018
Neutrophilia as prognostic biomarker in locally advanced stage III lung cancerAntoine Schernberg, Laura Mezquita, Angela Boros, et al.American Journal of Ophthalmology Case Reports|February 9, 2026
Bilateral myelin oligodendrocyte glycoprotein antibody-associated disease after cataract surgeryBenjamin Besse, Amélie Dos Santos, Mathieu Mille, et al.Targeted Oncology|May 7, 2009
QT interval prolongation among patients treated with angiogenesis inhibitorsStephane Ederhy, Ariel Cohen, Ghislaine Dufaitre, et al.Cancer Treatment Reviews|January 3, 2026
Intracranial activity of antibody-drug conjugates in advanced non-small cell lung cancer: What have we accomplished so far?Seng Wee Cheo, Molly S C Li, Derek De-Rui Huang, et al.Critical Reviews in Oncology/Hematology|August 28, 2021
Dynamics of eligibility criteria for central nervous system metastases in non-small cell lung cancer randomized clinical trials over time: A systematic reviewJanna Josephus Anna Oda Schoenmaekers, Safiye Dursun, Charlotte Biesmans, et al.Cancer Treatment Reviews|February 20, 2025
Antibody-drug conjugates in NSCLC with actionable genomic alterations: Optimizing smart delivery of chemotherapy to the targetGiannis Mountzios, Stephanie P L Saw, Lizza Hendriks, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 12, 2009
Use of adjuvant chemotherapy in non-small cell lung cancer in routine practiceChristophe Massard, Pierre Tran Ba Loc, Vincent Haddad, et al.Pageof 53